Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

BCMA antibody (AA 78-184)

The Mouse Monoclonal anti-BCMA antibody is suitable to detect BCMA in samples from Human. It has been validated for ELISA and IHC.
Catalog No. ABIN6940533
$640.46
Plus shipping costs $50.00
Shipping to: United States
Delivery in 2 to 5 Business Days

Quick Overview for BCMA antibody (AA 78-184) (ABIN6940533)

Target

See all BCMA (TNFRSF17) Antibodies
BCMA (TNFRSF17) (Tumor Necrosis Factor Receptor Superfamily, Member 17 (TNFRSF17))

Reactivity

  • 132
  • 23
  • 7
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 94
  • 39
  • 9
  • 2
  • 1
Mouse

Clonality

  • 103
  • 39
  • 3
Monoclonal

Conjugate

  • 85
  • 13
  • 6
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This BCMA antibody is un-conjugated

Application

  • 89
  • 53
  • 44
  • 39
  • 35
  • 27
  • 25
  • 23
  • 10
  • 5
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Immunohistochemistry (IHC)

Clone

BCMA-2366
  • Binding Specificity

    • 35
    • 33
    • 14
    • 7
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 78-184

    Purpose

    CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) Antibody

    Specificity

    The B cell maturation protein (BCMA) is a type I integral membrane protein that belongs to the tumor necrosis factor receptor (TNF-R) superfamily. It is expressed as a 184 amino acid peptide that is expressed only in mature B-lymphocytes and is located on the cis part of the Golgi apparatus. BCMA shares significant homology with TACI (transmembrane activator) within the cysteine-rich domain. TACI has been shown to bind CAML, which induces activation of NFAT (nuclear factor of activated T cells). Both BCMA and TACI have been shown to bind APRIL and TALL-1, which stimulate B cell proliferation in conjunction with other B-cell activators. When overexpressed, TALL-1 stimulates the development of systemic lupus erythaematosus (SLE).

    Purification

    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant human CD269 protein fragment (around aa 78-184) (exact sequence is proprietary)

    Isotype

    IgG2c, kappa
  • Application Notes

    Positive Control: NAMALWA cells. Tonsil or gastric carcinoma (IHC).

    Known Application: ELISA (For coating, order antibody without BSA),Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Expiry Date

    24 months
  • Target

    BCMA (TNFRSF17) (Tumor Necrosis Factor Receptor Superfamily, Member 17 (TNFRSF17))

    Alternative Name

    CD269

    Background

    B-cell maturation protein, BCMA, CD269, TNR17, Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)

    NAMALWA cells. Tonsil or gastric carcinoma (IHC).

    Molecular Weight

    20kDa

    Gene ID

    608, 2556

    UniProt

    Q02223
You are here:
Chat with us!